[PDF] Top 20 Detección de personas mediante redes convolucionales
Has 10000 "Detección de personas mediante redes convolucionales" found on our website. Below are the top 20 most common "Detección de personas mediante redes convolucionales".
An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease
... splenectomized patients, a selection is made for somewhat less severely affected patients, as splenectomy is generally associated with more advanced liver involvement and bone ... See full document
6
Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease
... Abstract: Gaucher disease (GD) is a heritable storage disorder caused by functional defects of the lysosomal acid β-glucosidase and the accumulation of glucosylceramide within macro- phages, resulting in ... See full document
38
Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease
... and treatment-switched adult patients In PB-06-001 (treatment-naïve adult patients), no ser- ious AEs were ...experienced treatment-related AEs were headache and pruritus. Two ... See full document
244
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy
... in patients who had not previously received enzyme therapy. Patients had to have had at least one bone crisis, osteoarticular necrosis, medullary infarction, lytic lesions, pathological fractures, fractures ... See full document
6
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
... treated patients (all doses combined, n = 158) when compared to placebo (n = 75) at 12 weeks ...of patients on 10 mg of mavrilimumab, in 61% of those on 30 mg, in ...mg. Patients started to show ... See full document
9
An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
... The evidence of efficacy in all domains including dactylitis and enthesitis might incline rheumatologists to choose this TNFi in patients in whom these conditions ...has evidence from randomized ... See full document
40
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma
... the treatment of multiple myeloma (MM), since by suppressing nuclear factor-κB activity, which promotes myelomagenesis, it makes plasma cells susceptible to proapoptotic ...in patients with ... See full document
11
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation
... AF patients are first stratified into low, intermediate, and high risk for thromboembolic events using the CHADS 2 and CHA 2 DS 2 -VASc score ...risks, patients are treated with either therapeutic ... See full document
9
Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes
... ate in intensity, and they either responded to medication or spontaneously resolved; a number of these infections were self-reported and could not be confirmed by microbiological culture testing. These adverse events ... See full document
26
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
... the treatment of cSSTIs, bacteremia, and RIE caused by susceptible Gram-positive bacteria in ...valuable treatment option in the management of other Gram-positive and difficult-to-treat infections, ... See full document
12
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
... castrate-resistant disease will continue to respond to secondary hormonal manipulations such as other antiandrogens, estrogen agonists, corticosteroids and steroidogenesis inhibitors (eg, ... See full document
22
<p>Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data</p>
... Additional doravirine resistance data is beginning to emerge. One analysis evaluated 9764 sequences of ARV- naïve samples in France, Greece, and Italy for the develop- ment of doravirine resistance-associated mutations ... See full document
6
An evidence-based review of natalizumab therapy in the management of Crohn’s disease
... Crohn’s disease and ...exposed patients in ENACT-1 and ENACT-2 trials ...of patients in the placebo group and 11% of those who received ...of patients in the placebo group and 5% of those in ... See full document
8
Potential of afatinib in the treatment of patients with HER2-positive breast cancer
... in patients with HER2- negative breast cancer: NCT00425854 is a recently completed open-label Phase II trial to assess the efficacy and safety of a once-daily oral dose of 50 mg afatinib in two cohorts of ... See full document
51
Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia
... the disease is considered to have progressed to an aggressive, acute form of leukemia that is rapidly fatal, with a median survival of 3–6 ...of patients because those whose leukemia is in lymphoid blast ... See full document
6
Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer
... in patients with thyroid cancers and therefore this is probably the population who would gain the most benefit from aggressive treatment of this ...female patients can often have a long lifespan ... See full document
5
Review of mifamurtide in the treatment of patients with osteosarcoma
... The disease, however, is very rare with less than 2,000 expected patients at all age groups per year within the European Union and the United States of ...of patients with localized osteosarcoma can ... See full document
10
An evidence-based review of linezolid for the treatment of methicillin-resistant <em>Staphylococcus aureus</em> (MRSA): place in therapy
... mortality. Treatment options have become limited due to the emergence of MRSA strains with decreased sensitiv- ity to vancomycin, which has long been the first-line therapy for serious ...for treatment of ... See full document
14
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
... of patients achieving A 1c ...all treatment groups compared to placebo ...seven patients (one for placebo, three for ...T2DM patients, dulaglutide lowered the A 1c and FPG, while promoting ... See full document
8
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
... available treatment options are not selective and, as such, have undesirable side ...successful treatment option for adult patients with moderate-to-severe ... See full document
5
Related subjects